
Blueprint Medicines Corporation
Blueprint Medicines Corporation (BPMC) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · BPMC · as of Jun 9, 2026
Key Statistics
Explore Blueprint Medicines Corporation Data
bpmc stock data · financialsCompetitors & Peers
bpmc competitorsAbout Blueprint Medicines Corporation
Blueprint Medicines Corporation is a biopharmaceutical company dedicated to pioneering precision therapies. Its core mission involves developing innovative treatments for various cancers and specific …
what is blueprint medicines corporation · bpmc stock overview · blueprint medicines corporation company profile · who is blueprint medicines corporation ceo · bpmc NASDAQ · blueprint medicines corporation headquarters · blueprint medicines corporation business segments
About Stock Overview & Key Data
Blueprint Medicines Corporation (BPMC) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Apr 30, 2015. As of the latest trading session, BPMC stock price is $129.46, with a market capitalization of $8.4B. The stock has returned — over the past 12 months and — year-to-date.
Frequently Asked Questions
As of the latest trading session, Blueprint Medicines Corporation (BPMC) stock price is $129.46. The stock is traded on NASDAQ under the ticker symbol BPMC. The 52-week range is $73.04 – $129.55.